High Risk of Severe Anaemia after Chlorproguanil-Dapsone+Artesunate Antimalarial Treatment in Patients with G6PD (A-) Deficiency

• Caterina I. Fanello ,

  * E-mail: Caterina.Fanello@ndm.ox.ac.uk

  Affiliations Centre for Vaccinology and Tropical Medicine, Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom, Mahidol-Oxford Tropical Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

  ⨯
• Corine Karema,

  Affiliation National Malaria Control Program, Kigali, Rwanda

  ⨯
• Pamela Avellino,

  Affiliation Department of Public Health Sciences, University of Rome La Sapienza, Rome, Italy

  ⨯
• Germana Bancone,

  Affiliation Department of Public Health Sciences, University of Rome La Sapienza, Rome, Italy

  ⨯
• Aline Uwimana,

  Affiliation National Malaria Control Program, Kigali, Rwanda

  ⨯
• Sue J. Lee,

  Affiliations Centre for Vaccinology and Tropical Medicine, Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom, Mahidol-Oxford Tropical Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

  ⨯
• Umberto d'Alessandro,

  Affiliation Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium

  ⨯
• David Modiano

  Affiliation Department of Public Health Sciences, University of Rome La Sapienza, Rome, Italy

  ⨯